Breaking News Instant updates and real-time market news.

EVH

Evolent Health

$15.65

-0.8 (-4.86%)

17:45
09/19/17
09/19
17:45
09/19/17
17:45

Evolent Health initiated with an Overweight at KeyBanc

KeyBanc analyst Donald Hooker started Evolent Health with an Overweight rating and $23 price target. The company offers an attractive way to play the transformation of U.S. healthcare to value-based reimbursement, the analyst contends.

  • 25

    Sep

EVH Evolent Health
$15.65

-0.8 (-4.86%)

09/06/17
JEFF
09/06/17
NO CHANGE
Target $28
JEFF
Buy
Jefferies calls Evolent 'easy buy' after management meeting
Jefferies analyst Sean Dodge says Evolent Health shares are down 27% since the company's Q2 results on August 7 due to "overblown concerns" around 2018 revenue growth and use of proceeds from the primary share offering. After meeting with management, the analyst notes Evolent remains confident in its long-term outlook and that there are multiple near-term catalyst for the shares. Dodge believes Evolent's revenue will grow 25%-plus in 2018, even without another new client, and the $175M capital raise "foreshadows some big contract wins." He sees "little chance" of another secondary offering now that private equity ownership is mostly removed. Valuation makes Evolent "an easy buy," Dodge tells investors. He recommends buying the shares and keeps a Buy rating on the name with a $28 price target.
08/18/17
LEER
08/18/17
NO CHANGE
Target $32
LEER
Outperform
Leerink views CMS proposal as only modest negative for Evolent
Leerink analyst David Larsen says shares of Evolent Health traded lower this week after the Centers for Medicare & Medicaid Service announced a proposed rule that scales back the Comprehensive Care for Joint Replacement model and cancels the mandatory Episode Payment Models and Cardiac Rehabilitation Incentive payment model which were slated to begin in January 2018. The move by CMS is a "modest negative" for Evolent because cardiac care and joint replacements tend to be high revenue and earnings drivers for hospitals, Larsen tells investors in a research note. The analyst, however, remains positive on the shares. He believes that with or without these two programs, the industry-wide shift towards value-based care will continue. Larsen keeps an Outperform rating on Evolent with a $32 price target.
08/18/17
JPMS
08/18/17
NO CHANGE
JPMS
Overweight
Evolent Health 29% selloff this week overdone, says JPMorgan
JPMorgan analyst Stephanie Davis views the 29% selloff this week in shares of Evolent Health following the company's Q2 results as overdone. The analyst says the pullback is a buying opportunity. Davis, while acknowledging that FY18 is a larger contract renewal year for Evolent, notes the Q2 results did not change her long term thesis. The analyst continues to believe in the company's "superior positioning to win in the shift to value based care." She keeps an Overweight rating on Evolent Health.
08/08/17
BARD
08/08/17
NO CHANGE
Target $35
BARD
Outperform
Evolent Health shares inexpensive relative to growth, says Baird
Baird analyst Matthew Gillmor noted Evolent Health reported better than expected Q2 results and raised guidance. He said the pipeline is deep with large opportunities, yet he believes investors may be confused with regards to 2018 visibility. The analyst said shares are simply too inexpensive relative to the company's organic growth rate and he expects its valuation will reset higher at some point. Gillmor reiterated his Outperform rating and $35 price target on Evolent Health shares.

TODAY'S FREE FLY STORIES

NFLX

Netflix

09:00
10/17/17
10/17
09:00
10/17/17
09:00
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Fed funds futures are modestly lower, having unwound early gains »

Fed funds futures are…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production to be reported at 09:15 »

September Industrial…

09:00
10/17/17
10/17
09:00
10/17/17
09:00
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

September Industrial…

ACN

Accenture

$139.09

-0.11 (-0.08%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Hot Stocks
Accenture enters into exclusive negotiations to acquire Altima »

Accenture has entered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Earnings
Johnson & Johnson backs FY17 revenue view $75.9B-$76.2B, consensus $75.83 »

Guidance in constant…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

LRCX

Lam Research

$192.36

2.46 (1.30%)

08:59
10/17/17
10/17
08:59
10/17/17
08:59
Recommendations
Lam Research analyst commentary  »

Lam Research added to US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:57
10/17/17
10/17
08:57
10/17/17
08:57
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

08:56
10/17/17
10/17
08:56
10/17/17
08:56
General news
Redbook Store Sales data reported »

Week of 10/14 Redbook…

SRPT

Sarepta

$50.73

0.16 (0.32%)

08:56
10/17/17
10/17
08:56
10/17/17
08:56
Recommendations
Sarepta analyst commentary  »

Sarepta approaching…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

NFLX

Netflix

$202.68

3.19 (1.60%)

, GE

General Electric

$23.36

0.38 (1.65%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Options
Notable open interest changes for October 17th »

Monday's total…

NFLX

Netflix

$202.68

3.19 (1.60%)

GE

General Electric

$23.36

0.38 (1.65%)

CMCSA

Comcast

$36.61

0.6 (1.67%)

BAC

Bank of America

$26.24

0.41 (1.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 20

    Oct

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

08:55
10/17/17
10/17
08:55
10/17/17
08:55
General news
The U.S. trade price report beat estimates »

The U.S. trade price…

NOW

ServiceNow

$121.40

-0.89 (-0.73%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
ServiceNow to hold a forum »

NowForum 2017 is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

  • 26

    Oct

  • 11

    Dec

GSM

Ferroglobe

$14.56

0.39 (2.75%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
Ferroglobe to hold investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

  • 15

    Nov

MSBI

Midland States

$33.03

-0.07 (-0.21%)

08:55
10/17/17
10/17
08:55
10/17/17
08:55
Conference/Events
Midland States to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 27

    Oct

  • 15

    Nov

HPE

HP Enterprise

$14.86

-0.03 (-0.20%)

08:53
10/17/17
10/17
08:53
10/17/17
08:53
Initiation
HP Enterprise initiated  »

HP Enterprise initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 11

    Dec

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:51
10/17/17
10/17
08:51
10/17/17
08:51
Hot Stocks
Johnson & Johnson says Puerto Rico hurricane had limited impact on company »

Says impact was limited…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

PX

Praxair

$141.29

-0.92 (-0.65%)

08:51
10/17/17
10/17
08:51
10/17/17
08:51
Hot Stocks
Praxair signs long-term agreement to supply nitrogen to GLOBALFOUNDRIES »

Praxair has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ERII

Energy Recovery

$8.21

0.02 (0.24%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Initiation
Energy Recovery initiated  »

Energy Recovery initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 16

    May

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

CSX

CSX

$52.84

0.01 (0.02%)

08:49
10/17/17
10/17
08:49
10/17/17
08:49
Hot Stocks
CSX expects Q4 volume to be neutral »

CSX has a favorable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 29

    Oct

  • 30

    Oct

BOLD

Audentes Therapeutics

$25.00

-3.075 (-10.95%)

08:47
10/17/17
10/17
08:47
10/17/17
08:47
Initiation
Audentes Therapeutics initiated  »

Audentes Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

MS

Morgan Stanley

$48.94

0.64 (1.33%)

08:46
10/17/17
10/17
08:46
10/17/17
08:46
Hot Stocks
Morgan Stanley: MiFID to be 'a little bumpy,' not everyone ready for switchover »

Says believes MiFID will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

JNJ

Johnson & Johnson

$136.12

-0.31 (-0.23%)

08:46
10/17/17
10/17
08:46
10/17/17
08:46
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

Johnson & Johnson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

DNKN

Dunkin' Brands

$55.34

-0.13 (-0.23%)

08:46
10/17/17
10/17
08:46
10/17/17
08:46
Recommendations
Dunkin' Brands analyst commentary  »

Dunkin' Brands may…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 01

    Nov

  • 02

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.